Cvi Holdings, LLC Aeglea Bio Therapeutics, Inc. Transaction History

Cvi Holdings, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Aug 14, 2019	SELL	$6.1 - $8.78 $1.66 Million - $2.38 Million	-271,542 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$7.6 - $9.4 $2.06 Million - $2.55 Million	271,542 New	271,542 $2.19 Million

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Cvi Holdings, LLC with notifications on news.